계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Maze Therapeutics
company
About
Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.
- 101 - 250
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $190M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Maze Therapeutics is a biotechnology firm used to focus on translating genetic insights into new medicines. The company's translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, functional genomics, and an array of drug discovery approaches. and it also reveals modifier genes that confer protection and provide a deeper understanding of the target biology and how these targets can be targeted with drug therapies, enabling patients with protection against diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$381M
Maze Therapeutics has raised a total of
$381M
in funding over 2 rounds. Their latest funding was raised on
Jan 10, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 10, 2022 | Series Unknown | $190M | 1 | — | — | Detail |
| Feb 28, 2019 | Series A | $191M | 1 |
ARCH Venture Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Maze Therapeutics is funded by 2 investors.
ARCH Venture Partners
and General Catalyst
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
Yes | Series A |
General Catalyst
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
